| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 2536 | 2023 |
| Nonalcoholic fatty liver disease: pathology and pathogenesis DG Tiniakos, MB Vos, EM Brunt Annual Review of Pathology: Mechanisms of Disease 5 (1), 145-171, 2010 | 1078 | 2010 |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 938 | 2021 |
| Cellular senescence drives age-dependent hepatic steatosis M Ogrodnik, S Miwa, T Tchkonia, D Tiniakos, CL Wilson, A Lahat, CP Day, ... Nature communications 8 (1), 15691, 2017 | 886 | 2017 |
| Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis S McPherson, T Hardy, JF Dufour, S Petta, M Romero-Gomez, M Allison, ... Official journal of the American College of Gastroenterology| ACG 112 (5 …, 2017 | 759 | 2017 |
| TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ... Nature communications 5 (1), 4309, 2014 | 728 | 2014 |
| Histopathology of nonalcoholic fatty liver disease EM Brunt, DG Tiniakos World journal of gastroenterology: WJG 16 (42), 5286, 2010 | 622 | 2010 |
| Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia International Consensus Group for Hepatocellular Neoplasia Hepatology 49 (2), 658-664, 2009 | 467 | 2009 |
| Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020 | 417 | 2020 |
| KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program J Van Krieken, A Jung, T Kirchner, F Carneiro, R Seruca, FT Bosman, ... Virchows Archiv 453, 417-431, 2008 | 392 | 2008 |
| The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines GM Hirschfield, JK Dyson, GJM Alexander, MH Chapman, J Collier, ... Gut 67 (9), 1568-1594, 2018 | 376 | 2018 |
| Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis O Govaere, S Cockell, D Tiniakos, R Queen, R Younes, M Vacca, ... Science translational medicine 12 (572), eaba4448, 2020 | 298 | 2020 |
| Fibrosis and alcohol-related liver disease C Lackner, D Tiniakos Journal of hepatology 70 (2), 294-304, 2019 | 264 | 2019 |
| Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ... Journal of hepatology 75 (4), 770-785, 2021 | 259 | 2021 |
| Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease MD Kontogianni, N Tileli, A Margariti, M Georgoulis, M Deutsch, ... Clinical Nutrition 33 (4), 678-683, 2014 | 257 | 2014 |
| Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial D Houghton, C Thoma, K Hallsworth, S Cassidy, T Hardy, AD Burt, ... Clinical Gastroenterology and Hepatology 15 (1), 96-102. e3, 2017 | 253 | 2017 |
| Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease T Hardy, M Zeybel, CP Day, C Dipper, S Masson, S McPherson, ... Gut 66 (7), 1321-1328, 2017 | 221 | 2017 |
| NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma CL Wilson, D Jurk, N Fullard, P Banks, A Page, S Luli, AM Elsharkawy, ... Nature communications 6 (1), 6818, 2015 | 186 | 2015 |
| Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? R Younes, O Govaere, S Petta, L Miele, D Tiniakos, A Burt, E David, ... Gut 71 (2), 382-390, 2022 | 166 | 2022 |
| Diagnosis and assessment of NAFLD: definitions and histopathological classification AD Burt, C Lackner, DG Tiniakos Seminars in liver disease 35 (03), 207-220, 2015 | 165 | 2015 |
